射血分数降低的心力衰竭合并功能性三尖瓣反流与超额死亡相关
校正混杂因素后,FTR严重程度与长期死亡率独立相关,重度FTR 5年生存率仅34±4%,提示应开展针对FTR治疗的临床试验。
要点
- 心衰合并FTR常见(88%),且与肺动脉压升高、房颤、更重心衰表现独立相关。
- FTR严重程度与死亡率独立相关,重度FTR校正HR 1.57(1.39-1.78)。
- 5年生存率随FTR加重而下降:微量68±1%、轻度58±2%、中度45±2%、重度34±4%。
核心结论
- 在射血分数降低的心衰患者中,FTR常见且独立与肺动脉高压、房颤及更严重心衰表现相关。
- 长期随访中,FTR严重程度越高,生存率越差,且独立于基线特征。
研究设计与样本
- 排除起搏器/除颤器、器质性瓣膜病或既往瓣膜手术患者;主要终点为全因死亡(截尾于植入除颤器、心室辅助装置或心脏移植)。
主要发现
- 与微量三尖瓣反流相比,FTR严重程度越高死亡风险越高:轻度校正HR 1.09(1.01-1.17),中度1.21(1.11-1.33),重度1.57(1.39-1.78)。
- 5年生存率:微量68±1%、轻度58±2%、中度45±2%、重度34±4%。
- FTR独立相关因素包括收缩期肺动脉压升高、年龄较大、女性、射血分数较低、二尖瓣反流和房颤(均P<0.0001)。
- FTR独立与更严重呼吸困难、肾功能受损和心输出量降低相关(均P<0.003)。
临床怎么用
- 在心衰射血分数降低患者中,应评估并分级功能性三尖瓣反流,因其与预后独立相关。
- 对于中重度FTR患者,需考虑更密切随访和个体化治疗策略,但原文未提供具体干预推荐。
局限性
- 原文未明确报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Functional tricuspid regurgitation (FTR) is common in heart failure with reduced ejection fraction and mostly consequent to pulmonary hypertension. However, the intrinsic clinical implications of FTR are not fully understood. METHODS: The cohort of all Mayo Clinic patients from 2003 to 2011 diagnosed with heart failure stage B-C and ejection fraction<50%, with FTR grading and systolic pulmonary artery pressure estimation by Doppler echocardiography was identified and outcomes were analyzed. Patients with pacemakers/defibrillators, organic valve disease, or previous valve surgery were excluded. The primary outcome measure was overall mortality (censored at implantation of a defibrillator, ventricular assist device, or cardiac transplantation), adjusting for clinical and echocardiographic associates with mortality and major comorbidities. RESULTS: Among 13 026 patients meeting inclusion criteria, FTR was detected in 88% (N=11 507: 33% trivial, 32% mild, 17% moderate, and 6% severe), aged 68±14 years, 35% women, ejection fraction 36±10%, systolic pulmonary artery pressure 41±14 mm Hg with 20% atrial fibrillation. Covariates independently associated with FTR included elevated systolic pulmonary artery pressure, older age, female sex, lower ejection fraction, mitral regurgitation, and atrial fibrillation (all P<0.0001). FTR was independently associated with more dyspnea, impaired kidney function, and lower cardiac output ( P<0.003 for all). For long-term outcome, higher FTR degree compared with trivial tricuspid regurgitation was independently associated with higher mortality (adjusted hazard ratios 1.09 [1.01-1.17] for mild FTR, 1.21 [1.11-1.33] for moderate FTR and 1.57 [1.39-1.78] for severe FTR); hence, 5-year survival was substantially lower with increasing severity of functional FTR, 68±1% for trivial FTR, 58±2% for mild FTR, 45±2% for moderate FTR, and 34±4% for severe FTR. CONCLUSIONS: In this large cohort of patients with heart failure with reduced ejection fraction, FTR was common and independently associated with pulmonary hypertension, atrial fibrillation, and more severe heart failure presentation. Long-term, higher FTR severity is associated with considerably worse survival, independently of baseline characteristics. Given these untoward outcomes associated with FTR in patients with heart failure with reduced ejection fraction, clinical trials should be directed at testing FTR treatment.
引用
- Benfari G, Antoine C, Miller WL, et al. Excess Mortality Associated With Functional Tricuspid Regurgitation Complicating Heart Failure With Reduced Ejection Fraction. Circulation. 2019. PMID: 31117814. doi:10.1161/CIRCULATIONAHA.118.038946
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。